Seoul, South Korea – In a candid and revealing YouTube video released on August 18th, South Korean transgender celebrity Harisu openly discussed the profound changes she has experienced since undergoing gender reassignment surgery (GRS) and provided an update on her current health status. Her frankness offers a rare glimpse into the long-term realities of gender transition, aging, and the persistent challenges faced by pioneering figures in the LGBTQ+ community. Harisu’s disclosure, particularly regarding her bone health, underscores the critical need for comprehensive, lifelong medical care and accessible information for transgender individuals.
A Pioneer’s Enduring Legacy and Early Struggles
Harisu, born Lee Kyung-eun and later transitioning to Lee Kyung-eop, became a household name in South Korea and across Asia in the early 2000s, shattering societal norms and paving the way for greater transgender visibility. Her journey to stardom, however, was fraught with significant obstacles. She recounted spending a decade toiling in obscurity, beginning her attempts to enter the entertainment industry in 1991. Despite her talent and aspirations, she faced consistent rejection and an inability to secure contracts due to her transgender identity.
"I debuted in the entertainment industry in 1991," Harisu revealed in the video. "I was cast in movies, dramas, and as an advertising model, but I couldn’t sign contracts because I was transgender. I stayed unknown for 10 years before getting an opportunity." This period of struggle highlights the immense discrimination and lack of understanding prevalent in the Korean entertainment industry and wider society at the time. The early 1990s in South Korea offered very limited public discourse or acceptance for transgender individuals, making her ambition to become a public figure almost unfathomable to many.
Her breakthrough arrived dramatically in 2001, when she was cast as the face of a cosmetics commercial. This campaign was revolutionary, not only for featuring an openly transgender model but also for the scale of its success. Harisu became an overnight sensation, reportedly earning ₩60.0 million KRW (approximately $43,200 USD at current exchange rates) in just six months from that single endorsement. She recalled the cosmetics company president’s insistence on casting her, a testament to her unique appeal and charisma. Her success was a watershed moment, making her the country’s first openly transgender celebrity and a symbol of both hope and controversy.
"My early 20s were my prime," Harisu reminisced, referring to the period following her debut. "It was the heyday in the transgender community." This era marked an unprecedented level of visibility and discussion surrounding transgender issues in South Korea, largely catalyzed by her groundbreaking presence in mainstream media. Her popularity extended beyond South Korea, garnering significant attention in China, Japan, and other parts of Southeast Asia, where she pursued a successful career in music, film, and television.
Long-Term Health Realities: Post-GRS and Hormone Therapy
Harisu’s journey is particularly significant given the timing of her gender reassignment surgery. She disclosed that she underwent GRS in 1995, nearly 30 years ago. This places her among the earlier generations of transgender individuals to access such medical procedures, often under conditions that were less understood or supported than today. Her long-term experience offers invaluable insights into the enduring physical and medical aspects of transition.
One of the most striking revelations in her recent video concerned her decision to discontinue hormone therapy. For many transgender women, lifelong hormone replacement therapy (HRT) is a crucial component of maintaining feminization, bone density, and overall well-being post-GRS. Harisu explained that she stopped taking female hormones due to the "burden" associated with continuous medication. While she did not elaborate on the specific nature of this burden, it could encompass a range of factors including cost, side effects, the psychological weight of daily medication, or a perceived decrease in necessity over time.
This decision, however, has had significant health implications. Harisu revealed that she was diagnosed with early osteoporosis approximately six years ago. The severity of her condition was particularly alarming: "My bones were in worse condition than my 80-year-old mother’s," she stated, expressing profound surprise at the diagnosis.
The Critical Link Between Hormone Therapy and Bone Health
Harisu’s experience brings into sharp focus the critical role of estrogen in maintaining bone density, particularly for transgender women who have undergone orchiectomy (removal of testes) as part of GRS. Estrogen plays a vital role in bone remodeling, preventing bone loss, and promoting bone formation. Without adequate levels of estrogen, either naturally produced or supplemented through HRT, individuals are at a significantly higher risk of developing osteoporosis, a condition characterized by weak, brittle bones.
Medical guidelines for transgender women typically recommend lifelong HRT post-GRS, not only for maintaining secondary sexual characteristics but also for skeletal health. Discontinuing HRT, especially after surgical removal of the primary source of testosterone (which is converted to estrogen in the body, or directly replaced by exogenous estrogen), can lead to a rapid decline in bone mineral density. This risk is compounded by other factors such as age, lifestyle (Harisu mentioned she doesn’t exercise regularly), and genetic predispositions.
The prevalence of osteoporosis is a growing concern globally, but its specific impact on the aging transgender population is an area that requires more dedicated research and clinical attention. Harisu’s case serves as a poignant reminder that long-term medical follow-up and patient education are paramount for transgender individuals to manage their health effectively throughout their lifespan.
Aging, Appearance, and the Search for Information
Beyond the significant bone health revelation, Harisu also candidly discussed the realities of aging and maintaining her appearance in the public eye. She admitted to visiting a dermatologist for the first time in eight years, noting the natural changes occurring with age. "As I got older, bruises started appearing on my face, and my skin changed," she observed. She also shared her experience with cosmetic procedures like Botox, stating, "The effect lasts only about 2 to 3 months and it doesn’t really work." Her honesty about the limitations of such treatments and the natural process of aging resonates with many, both within and outside the transgender community, who grapple with societal pressures to maintain youthfulness.
A particularly poignant aspect of her current situation is her feeling of isolation regarding health information. "It’s hard to start female hormone therapy again now," she shared, expressing her current concerns. "Since I’m living outside the gender world now, I don’t have any information either." This statement highlights a significant gap in healthcare infrastructure and support systems for older transgender individuals. After decades of pioneering visibility, Harisu now finds herself in a position where accessible and tailored medical advice for her unique long-term health needs is scarce. This lack of information is a systemic issue, often stemming from healthcare providers’ limited training in transgender-specific care, particularly for aging populations.
Broader Implications and the Need for Comprehensive Care
Harisu’s candid revelations carry several significant implications:
- Advocacy for Long-Term Transgender Healthcare: Her story powerfully illustrates the need for comprehensive, culturally competent, and lifelong medical care for transgender individuals. This includes not only initial transition-related care but also ongoing monitoring for conditions like osteoporosis, cardiovascular disease, and other age-related health issues that might be influenced by past or present hormone use.
- Addressing Information Gaps: The fact that a prominent figure like Harisu feels a lack of information underscores a broader systemic problem. Healthcare systems need to develop better resources, guidelines, and educational programs for both patients and providers regarding the long-term health management of transgender individuals, especially those who transitioned decades ago.
- Destigmatizing Aging in the Transgender Community: By openly discussing her aging skin, the ineffectiveness of some cosmetic procedures, and her bone health, Harisu contributes to destigmatizing aging within the transgender community, which often faces immense pressure to maintain specific aesthetic standards.
- Public Understanding: Her openness helps to educate the general public about the complexities of transgender health beyond the initial stages of transition, fostering a more nuanced understanding of the lived experiences of transgender individuals throughout their lives.
- Historical Context of Transgender Medicine: Harisu’s 1995 surgery date reminds us that medical understanding and practices surrounding GRS and HRT have evolved significantly. Earlier procedures and treatment protocols may have different long-term outcomes, necessitating individualized and informed care for these pioneering individuals.
In South Korea, while there has been progress in LGBTQ+ rights and visibility since Harisu’s debut, significant challenges remain. Transgender individuals still face legal hurdles, social discrimination, and often limited access to specialized healthcare. Harisu’s continuing willingness to share her personal journey provides invaluable insights, pushing the conversation forward and advocating, perhaps inadvertently, for improved healthcare and support systems for all transgender people. Her story is not just a personal anecdote but a crucial data point in the ongoing effort to understand and address the unique health needs of an aging transgender population worldwide.